Allogeneic Transplantation

Women who undergo allogeneic hematopoietic cell transplantation can get pregnant and have healthy children, according to results of a retrospective study conducted in Germany.

Sinusoidal obstructive syndrome is a rare but potentially serious complication that can occur after hematopoietic stem cell transplantation.

Myelodysplastic syndrome predominantly affects older adults, with median age of onset of 70 years.

Healio spoke with David Andrew Sallman, MD, about unmet needs in myelodysplastic syndrome.

Chronic graft-versus-host disease continues to be a leading cause of late morbidity and mortality, complicating approximately 35% to 50% of allogeneic transplantations.

NEW ORLEANS — In this video perspective, Richard M Stone, MD, discusses data from the randomized phase 3 ASAP trial, which was presented at ASH Annual Meeting and Exposition.

The FDA granted priority review to omidubicel, an investigational donor-based stem cell therapy for patients with hematologic malignancies undergoing allogeneic hematopoietic stem cell transplantation.

SALT LAKE CITY — Axatilimab appeared effective for heavily pretreated patients with active chronic graft-versus-host disease, according to phase 1/phase 2 study results.

SALT LAKE CITY — Allogeneic hematopoietic stem cell transplantation appeared effective for patients with high-risk subtypes of acute lymphoblastic leukemia, according to study results.

SALT LAKE CITY — Abatacept demonstrated efficacy among patients with steroid-refractory chronic graft-versus-host-disease, according to phase 2 study results.